Easy PGX Archivi - Seite 6 von 7 - Diatech

23 08, 2021

Martina Lorenzi et al., First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.

adlitterio663392021-08-23T12:10:15+02:00

22 07, 2021

Alessandro Pancrazzi et al., Experience of Uncommon EGFR Mutation in Lung Scheme Quality Program: Discussing Risks and Opportunities for the Improvement of Laboratory Response

adlitterio663392022-10-14T12:20:42+02:00

1 07, 2021

Cristina Morelli et al., Perfect concordance between blood-based and normal tissue-based dihydropyrimidine dehydrogenase polymorphisms suggests that pharmacogenetic screening could be contextual to tumour molecular profiling

adlitterio663392022-10-14T12:26:32+02:00

16 04, 2021

Michela Marina et al., Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study

adlitterio663392021-04-16T15:40:56+02:00

7 04, 2021

Lisa Elefanti et al., The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI).

adlitterio663392022-10-14T12:30:58+02:00

17 03, 2021

Umberto Malapelle et al., Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective.

adlitterio663392022-10-14T14:08:32+02:00

4 03, 2021

Enea Ferlizza et al., The Roadmap of Colorectal Cancer Screening

adlitterio663392023-05-08T15:54:02+02:00

17 02, 2021

Josè Nunnari et al., Rapid EGFR evaluation from used H&E, IHC and FISH diagnostic slides with the Idylla platform

adlitterio663392022-10-14T14:11:09+02:00

29 12, 2020

Vincenzo Formica et. al., Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients—The Importance of Tissue/Plasma Discordant Cases

Diatech Pharmacogenetics2020-12-29T11:28:18+01:00

1 07, 2020

Jessica Lucchetti et. al., Value of liquid biopsy using high-affinity plasma DNA binding magnetic beads and qualitative real-time PCR for KRAS, NRAS and BRAF mutations in metastatic colorectal cancer patients

Diatech Pharmacogenetics2020-11-03T14:45:36+01:00

Vorheriges 567 Nächstes